Modalities

  1. Home

  2. caret-right icon

    Immunoassays

  3. caret-right icon

    Modalities

Supporting modern biotherapeutics 

New therapeutic approaches are changing how diseases are treated. Antibody-based medicines, nucleic acid therapies, vaccines, and gene therapies all bring new possibilities for patients. At the same time, they introduce new analytical questions. Scientists need reliable data to understand these complex molecules - from early development to clinical studies and manufacturing.

The Gyrolab automated immunoassay platform supports a wide range of therapeutic modalities with automated, nanoliter-scale immunoassays. By reducing manual work and using small sample volumes, the platform helps teams generate consistent data and move forward with confidence.

 

Modalities we support

Each modality comes with its own analytical challenges. Gyrolab immunoassays help teams measure critical attributes such as potency, concentration, immunogenicity, and biomarkers across a range of biologic formats.

Explore how Gyrolab supports the following therapeutic modalities.

  • Antibody–Drug Conjugate (ADC)

    ADCs combine the targeting ability of antibodies with a potent cytotoxic drug. Their complexity requires careful measurement of attributes such as drug-to-antibody ratio (DAR), pharmacokinetics, and immunogenicity.
    View ADCs

  • Antibody Therapeutics

    Monoclonal antibodies remain one of the most widely used classes of biologic medicines. Their development relies on accurate measurements of binding, concentration, pharmacokinetics, and immune response.
    View Antibody Therapeutics

  • Biosimilars

    Biosimilar development requires a detailed analytical comparison with the reference product. Scientists must demonstrate similarity across multiple functional and biological attributes.
    View Biosimilars

  • Oligonucleotides

    Oligonucleotide therapies — including antisense oligonucleotides, siRNA, and mRNA-based medicines — are an expanding area of drug development.
    View Oligonucleotides

  • Therapeutic Proteins

    Recombinant proteins and other therapeutic proteins are widely used across many disease areas. Their development requires reliable measurements of protein concentration, potency, immunogenicity, and impurities.ent. 
    View Therapeutic proteins

  • Vaccines

    Vaccines remain one of the most effective tools for preventing infectious diseases and are increasingly explored for immunotherapy.
    View Vaccines

  • Viral Vectors

    Viral vectors are widely used in gene therapies and new vaccines to deliver genetic material into cells.
    View Viral Vectors

Why teams use Gyrolab across modalities

Across different therapeutic approaches, many analytical needs remain the same: reliable results, efficient workflows, and the ability to work with limited samples.

Gyrolab helps teams:

    • Generate consistent immunoassay data
    • Work with small sample volumes
    • Reduce manual handling in assay workflows
    • Free up time for data interpretation and decision-making
    • Support studies in both research and regulated environments
Scientist woman

Talk to an expert

Talk with a specialist to discuss how automated immunoassays can support your development program.

Contact us today to discuss your analytical challenges or schedule a demonstration of the Gyrolab platform.